In the study of 1,697 Framingham Heart Study offspring members ages 30 or older, there was a dose-response relation between parental longeity and Framingham Risk Score, they said.

• 他们说，此次参加佛莱明翰心脏研究的后代成员有1697名，由30岁及30岁以上组成。父母长寿和佛莱明翰风险论点之间有着一种剂量-响应关系。